Interestingly, its relationship with tumor immunity evasion in some subsets of melanoma and colorectal tumors, where DKK-2 depletion activates natural killer (NK) cells and CD8+ T lymphocytes and impedes tumor progression, has also been described. This evidence concerns the gene DKK2 and neoplasm.